Significance of indeterminate reactivity to human T-Cell lymphotropic virus in Western blot analysis of individuals at risk

被引:11
作者
Medrano, FJ
Soriano, V
Calderon, EJ
Rey, C
Gutierrez, M
Bravo, R
Leal, M
GonzalezLahoz, J
Lissen, E
机构
[1] VIRGEN DEL ROCIO UNIV HOSP,DEPT INTERNAL MED,SEVILLE 41013,SPAIN
[2] VIRGEN DEL ROCIO UNIV HOSP,DEPT BIOCHEM,VIRAL HEPATITIS & AIDS STUDY GRP,SEVILLE 41013,SPAIN
[3] INST SALUD CARLOS III,CTR INVEST CLIN,INFECT DIS SERV,MADRID,SPAIN
[4] INST SALUD CARLOS III,CTR INVEST CLIN,MICROBIOL SERV,MADRID,SPAIN
关键词
D O I
10.1007/BF01709592
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Current tests to confirm human T-cell lymphotropic virus (HTLV) infection in individuals at risk of retroviral infection commonly yield indeterminate results. To assess the significance of HTLV-seroindeterminate reactivities in a high-risk population, 16 at-risk individuals who had this serologic pattern by Western blot were studied using a polymerase chain reaction (PCR) assay. Human T-cell lymphotropic virus type II infection was confirmed by the presence of virus-specific nucleic acid in four patients. However, PCR analysis was negative in the remaining 12 individuals. These results indicate strongly that all specimens from at-risk individuals with nondiagnostic HTLV reactivity by current Western blot assay should continue to be considered inconclusive, requiring further testing by more sensitive tests.
引用
收藏
页码:249 / 252
页数:4
相关论文
共 15 条
  • [1] BIGGAR RJ, 1987, NEW ENGL J MED, V316, P630, DOI 10.1056/NEJM198703053161015
  • [2] IMMUNE RESPONSIVENESS TO THE IMMUNODOMINANT RECOMBINANT ENVELOPE EPITOPES OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-1 AND TYPE-2 IN DIVERSE GEOGRAPHIC POPULATIONS
    BUCKNER, C
    ROBERTS, CR
    FOUNG, SKH
    LIPKA, J
    REYES, GR
    HADLOCK, K
    CHAN, L
    GONGORABIACHI, A
    HJELLE, B
    LAL, RB
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (05) : 1160 - 1163
  • [3] BUSCH MP, 1994, BLOOD, V83, P1143
  • [4] CALDERON E, 1995, ALPE ADRIA MICROBIOL, V2, P86
  • [5] PREVALENCE OF INFECTION BY HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I AND TYPE-II IN SOUTHERN SPAIN
    CALDERON, EJ
    REY, C
    MEDRANO, FJ
    SANCHEZROMAN, J
    SORIANO, V
    TORRES, Y
    RUIZ, M
    LISSEN, E
    LEAL, M
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (08) : 686 - 690
  • [6] *CDCP, 1993, ANN INTERN MED, V118, P448
  • [7] LOSS OF ANTIBODIES AGAINST HEPATITIS-C VIRUS IN HIV-SEROPOSITIVE INTRAVENOUS-DRUG-USERS
    CHAMOT, E
    HIRSCHEL, B
    WINTSCH, J
    ROBERT, CF
    GABRIEL, V
    DEGLON, JJ
    YERLY, S
    PERRIN, L
    [J]. AIDS, 1990, 4 (12) : 1275 - 1277
  • [8] EHRLICH GD, 1989, BLOOD, V74, P1658
  • [9] PREVALENCE OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1 (HTLV-1) AND HTLV-2 INFECTION AMONG SPANISH DRUG-USERS MEASURED BY HTLV-1 ASSAY AND HTLV-1 AND HTLV-2 ASSAY
    HENRARD, DR
    SORIANO, V
    ROBERTSON, E
    GUTIERREZ, M
    STEPHENS, J
    DRONDA, F
    MILES, F
    PUJOL, E
    BUYTENDORP, M
    CASTRO, A
    CHAN, E
    VALLEJO, A
    LLIBRE, J
    MOTLEY, C
    PRILLAMAN, J
    CALDERON, E
    LEAL, M
    TUSET, C
    MARTINEZZAPICO, R
    CABALLERO, E
    ORTIZ, R
    EIROS, J
    AGUILERA, A
    ULLOA, F
    MARTIN, AM
    RODRIGUEZIGLESIAS, A
    RIVERA, A
    BOUZA, E
    ESPARZA, B
    MERINO, F
    TOR, J
    ESCUDERO, D
    RIBERA, J
    DELROMERO, J
    RODRIGUEZ, C
    PEDREIRA, J
    HEREDIA, A
    HEWLETT, I
    GONZALEZLAHOZ, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (07) : 1735 - 1738
  • [10] HUMAN LYMPHOTROPIC-T VIRUS TYPE-II (HTLV-II) INFECTION IN A COHORT OF NEW-YORK INTRAVENOUS-DRUG-USERS - AN OLD INFECTION
    KHABBAZ, RF
    HARTEL, D
    LAIRMORE, M
    HORSBURGH, CR
    SCHOENBAUM, EE
    ROBERTS, B
    HARTLEY, TM
    FRIEDLAND, G
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) : 252 - 256